“COVID-19” and its Cardiovascular Complications – Review

Abstract

By the end of December in 2019, the world got trapped under the dark shadow of the deadly novel virus that was given the name as “Severe Acute Respiratory Syndrome‐coronaVirus 2 (SARS‐CoV‐2)”. Due to its rapid spread in all the continents, “Coronavirus disease 2019 (COVID-19)” was announced as the pandemic due to its high potential of infecting the human beings. This viral infection not only become the reason of mortality, but it also lethally effected the the infrastructure of public health care system and the global economic situation. “COVID-19” generally maifestated as the “viral pneumonia”, sporadically leading to “acute respiratory distress syndrome (ARDS)” and death. Frequent clinical studies have depicted an interrelation between this deadly virus and cardiovascular diseases. Precedent cardiovascular disease in a person seems to be linked with adverse consequences and high chances of mortality in patients with (COVID-19 infection), whereas this virus itself has a potential of inducing the arrhythmia, acute coronary syndrome, myocardial injury and venous thromboembolism. One of the most significant point of concern is the drug & disease interactions that affect the patients with viral infection and comorbid cardiovascular diseases. By integrating the data and information regarding the biological features of this contagious novel virus, this review has summarized the pivotal cardiac manifestations, their management, and future implications. By correlating the facts and figures related to the biological conditions of this lethal virus with the reported clinical findings, we can ameliorate our conceptions regarding the significant mechanisms underlying (COVID-19), ultimately leading towards the control of this viral infection by the progressive development in preventions and treatments